March 6th The Bayer Group completed the voluntary takeover offer for Norwegian pharmaceutical company Algeta ASA, Oslo. As a result, Bayer now holds 98.2 % of the shares and voting rights in Algeta. Bayer intends to initiate a compulsory acquisition process in order to acquire the remaining shares of minority shareholders in Algeta in the coming days. Bayer intends to file for delisting of the Algeta shares from the Oslo Stock Exchange (OSE).
Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. Algeta's lead product Xofigo® injection (radium Ra 223 dichloride, radium-223; previously called Alpharadin) is an alpha particle-emitting pharmaceutical with an anti-tumor effect on bone metastases.
In September 2009, Algeta signed an agreement with Bayer for the development and commercialization of Xofigo. Under the terms of this agreement, Bayer will develop, apply for health authority approvals worldwide and commercialize Xofigo globally. Algeta is eligible for royalties and milestones based on Bayer’s sales of Xofigo outside the US, and Algeta US is co-promoting Xofigo with Bayer in the US.
Algeta is also evaluating the potential of Targeted Thorium Conjugates (TTCs), which are based on conjugating the alpha-emitter thorium-227 to targeting molecules, as a basis of a potential future pipeline of tumor-targeting alpha-pharmaceutical candidates.
In December 2013, the Board of Directors of Algeta ASA announced that it had unanimously recommended the voluntary cash offer (the “Offer”) of NOK 362 per share from Bayer to acquire the entire issued share capital of Algeta.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Kjelsåsveien 172 A, Oslo,norway
- Phone
- +49 214 300
- po****@****eta.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- algeta.com
- Keywords
- Engineer jobs.
- HQ
- Oslo
Algeta Asa Questions
Algeta Asa's helpline number is +49 214 300
Algeta Asa's website is algeta.com
Algeta Asa's LinkedIn profile is https://www.linkedin.com/company/algeta-asa
Algeta Asa has
16 employees.
View email and phone details for 16
employees at Algeta Asa.
Algeta Asa's industry is
Pharmaceutical Manufacturing
Algeta Asa's top competitors are
Bionor Holding As,
Thor Medical Asa,
Vistin Pharma As,
Clarity Pharmaceuticals,
Blueprint Medicines,
Algipharma As,
Bayer,
Oncoinvent Asa,
Bayer Norge,
Circio Holding Asa.
Algeta Asa's support email address is post@algeta.com
Algeta Asa's categories are Pharmaceutical Manufacturing
Algeta Asa's founding year is 1997
